Form 4 Tracker
Ascendis Pharma A/S
ASND

5 insider filings · Latest: Jun 2, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 2, 2026Jun 2 8:25 PMScott Thomas SmithEVP & Chief Financial Officer
Purchase
100$219.00$21.9K4,367(D)

View →

May 29, 2026Jun 1 8:11 PMJean Jacques BienaimeDirector
Purchase
500$223.12$111.6K900(D)

View →

May 29, 2026Jun 1 8:10 PMScott Thomas SmithEVP & Chief Financial Officer
Purchase
250$223.32$55.8K4,267(D)

View →

May 26, 2026May 27 8:05 PMJean Jacques BienaimeDirector
Purchase
400$237.80$95.1K400(D)

View →

May 11, 2026May 12 8:08 PMFlemming Steen JensenEVP & Product Supply and Quality
Sale
19,460$238.49$4.6M0(D)

View →

May 11, 2026May 11 7:36 PMJENSEN FLEMMING STEEN
Proposed Sale
19,460$238.49$4.6M

View →

Mar 9, 2026Mar 9 9:30 PMSINGEL STINA
Proposed Sale
3,782$240.00$907.7K

View →

Mar 6, 2026Mar 6 9:21 PMBodenhoff Mads
Proposed Sale
10,000$237.53$2.4M

View →

Mar 5, 2026Mar 6 1:44 PMSMITH SCOTT THOMAS
Proposed Sale
10,000$240.00$2.4M

View →

Mar 5, 2026Mar 5 10:20 PMShu Aimee
Proposed Sale
5,583$235.81$1.3M

View →

Mar 5, 2026Mar 5 10:07 PMSMITH SCOTT THOMAS
Proposed Sale
10,000$240.00$2.4M

View →

Mar 5, 2026Mar 5 10:04 PMJan Moller Mikkelsen
Proposed Sale
94,000$241.38$22.7M

View →

Mar 4, 2026Mar 4 9:58 PMMorrison Lisa
Proposed Sale
10,105$236.34$2.4M

View →

Mar 4, 2026Mar 4 3:54 PMShu Aimee
Proposed Sale
7,290$239.22$1.7M

View →

Mar 2, 2026Mar 2 10:01 PMFairey William
Proposed Sale
1,800$242.09$435.8K

View →

Mar 2, 2026Mar 2 9:59 PMIMANI SIHAM
Proposed Sale
1,800$242.09$435.8K

View →

Mar 2, 2026Mar 2 9:56 PMSMITH SCOTT THOMAS
Proposed Sale
18,349$242.09$4.4M

View →

Mar 2, 2026Mar 2 9:52 PMJENSEN MICHAEL WOLFF
Proposed Sale
18,349$242.09$4.4M

View →

Mar 2, 2026Mar 2 9:44 PMBodenhoff Mads
Proposed Sale
6,872$242.09$1.7M

View →

Mar 2, 2026Mar 2 9:40 PMPEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG
Proposed Sale
10,800$242.09$2.6M

View →

Page 1 of 4

Next →

Stock Options & Derivatives

No transactions found.